Transcriptomics

Dataset Information

41

Mouse peripheral blood leukocytes cyclophosphamide treated vs untreated


ABSTRACT: Analysis of the effect of cyclophosphamide on peripheral blood leukocyte gene expression. Certain chemotherapeutic drugs such as cyclophosphamide can enhance the antitumor efficacy of immunotherapy because of their capacity to modulate innate and adaptive immunity. Indeed, it has been argued that this capacity may be more significant to chemotherapeutic efficacy in general than is presently appreciated. To gain insights into the core mechanisms of chemoimmunotherapy, we methodically profiled the effects of cyclophosphamide on gene expression in bone marrow, spleen and peripheral blood, and on cytokine expression in plasma and bone marrow of tumor-bearing mice. Gene and protein expression were modulated early and transiently by cyclophosphamide, leading to upregulation of a variety of immunomodulatory factors, including danger signals, pattern recognition receptors, inflammatory mediators, growth factors, cytokines, chemokines and chemokine receptors. These factors are involved in sensing cyclophosphamide myelotoxicity and activating repair mechanisms, which, in turn, stimulate immunoactivation events that promote efficacy. In particular, cyclophosphamide induced a T helper 17 (Th17)-related gene signature associated with an increase in Th17, Th1 and activated CD25+CD4+Foxp3- T lymphocytes and a slight recovery of regulatory T-cells. By analyzing gene and protein expression kinetics and their relationship to the antitumor efficacy of different therapeutic schedules of combination, we determined that optimal timing for performing adoptive immunotherapy is approximately 1 day after cyclophosphamide treatment. Together, our findings highlight factors that may propel the efficacy of chemoimmunotherapy, offering a mechanistic glimpse of the important immune modulatory effects of cyclophosphamide Four-condition experiment, Untreated mice - Cyclophosphamide-treated mice 1 day - Cyclophosphamide-treated mice 2 days - Cyclophosphamide-treated mice 5 days. Biological replicates: 4, controls: 4, independently harvested. Two replicates per array.

ORGANISM(S): Mus musculus  

SUBMITTER: Mara Valentini  Federica Moschella    

PROVIDER: E-GEOD-27422 | ArrayExpress | 2014-05-03

SECONDARY ACCESSION(S): GSE27422PRJNA141831

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide.

Moschella Federica F   Valentini Mara M   Aricò Eleonora E   Macchia Iole I   Sestili Paola P   D'Urso Maria Teresa MT   Alessandri Cristiano C   Belardelli Filippo F   Proietti Enrico E  

Cancer research 20110328 10


Certain chemotherapeutic drugs, such as cyclophosphamide (CTX), can enhance the antitumor efficacy of immunotherapy because of their capacity to modulate innate and adaptive immunity. Indeed, it has been argued that this capacity may be more significant to chemotherapeutic efficacy in general than is currently appreciated. To gain insights into the core mechanisms of chemoimmunotherapy, we methodically profiled the effects of CTX on gene expression in bone marrow, spleen, and peripheral blood, a  ...[more]

Similar Datasets

2014-05-03 | E-GEOD-27423 | ArrayExpress
2014-06-02 | E-GEOD-27421 | ArrayExpress
2014-06-02 | E-GEOD-39324 | ArrayExpress
2015-05-09 | E-GEOD-60867 | ArrayExpress
2015-05-09 | E-GEOD-60866 | ArrayExpress
2015-05-09 | E-GEOD-60864 | ArrayExpress
2013-05-09 | BIOMD0000000451 | BioModels Database
| GSE60977 | GEO
2014-06-03 | E-GEOD-53444 | ArrayExpress
2016-06-18 | E-GEOD-76356 | ArrayExpress